Ata, F.K., YALÇIN-AZARKAN, S. (2021) "Exosomes as delivery tools in cancer therapy: Future perspectives", NANOMEDICINE JOURNAL, 8 (3) pp. 156-165 [ESCI] Link DOI " data-bs-content-id="YazarBilgi-21699">
Ata, F.K., YALÇIN-AZARKAN, S. (2021) "Exosomes as delivery tools in cancer therapy: Future perspectives", NANOMEDICINE JOURNAL, 8 (3) pp. 156-165 [ESCI] Link DOI Ata, F.K., YALÇIN-AZARKAN, S. (2021) "Exosomes as delivery tools in cancer therapy: Future perspectives", NANOMEDICINE JOURNAL, 8 (3) pp. 156-165 [ESCI] Link DOI
Çankaya, N., YALÇIN-AZARKAN, S., Özek, N.T. (2021) "Preparation of poly(MPAEMA)/halloysite Nanocomposites and Investigation of Antiproliferative Activity", JOURNAL OF THE MEXICAN CHEMICAL SOCIETY, 65 (2) pp. 189-201 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21701">
Çankaya, N., YALÇIN-AZARKAN, S., Özek, N.T. (2021) "Preparation of poly(MPAEMA)/halloysite Nanocomposites and Investigation of Antiproliferative Activity", JOURNAL OF THE MEXICAN CHEMICAL SOCIETY, 65 (2) pp. 189-201 [SCI Expanded] DOI Çankaya, N., YALÇIN-AZARKAN, S., Özek, N.T. (2021) "Preparation of poly(MPAEMA)/halloysite Nanocomposites and Investigation of Antiproliferative Activity", JOURNAL OF THE MEXICAN CHEMICAL SOCIETY, 65 (2) pp. 189-201 [SCI Expanded] DOI
YALÇIN-AZARKAN, S., Gündüz, U. (2021) "Synthesis and biological activity of siRNA and Etoposide with magnetic nanoparticles on drug resistance model MCF-7 Cells: Molecular docking study with MRP1 enzyme", NANOMEDICINE JOURNAL, 8 (2) pp. 98-105 [ESCI] Link DOI " data-bs-content-id="YazarBilgi-21702">
YALÇIN-AZARKAN, S., Gündüz, U. (2021) "Synthesis and biological activity of siRNA and Etoposide with magnetic nanoparticles on drug resistance model MCF-7 Cells: Molecular docking study with MRP1 enzyme", NANOMEDICINE JOURNAL, 8 (2) pp. 98-105 [ESCI] Link DOI YALÇIN-AZARKAN, S., Gündüz, U. (2021) "Synthesis and biological activity of siRNA and Etoposide with magnetic nanoparticles on drug resistance model MCF-7 Cells: Molecular docking study with MRP1 enzyme", NANOMEDICINE JOURNAL, 8 (2) pp. 98-105 [ESCI] Link DOI
Mutlu, M., Mutlu, P., YALÇIN-AZARKAN, S., Bayır, Ö., Saylam, G., Korkmaz, M.H. (2020) "Evaluation of methylation profiles of an epidermal growth factor receptor gene in a head and neck squamous cell carcinoma patient group", BALKAN JOURNAL OF MEDICAL GENETICS, 23 (2) pp. 65-72 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21704">
Mutlu, M., Mutlu, P., YALÇIN-AZARKAN, S., Bayır, Ö., Saylam, G., Korkmaz, M.H. (2020) "Evaluation of methylation profiles of an epidermal growth factor receptor gene in a head and neck squamous cell carcinoma patient group", BALKAN JOURNAL OF MEDICAL GENETICS, 23 (2) pp. 65-72 [SCI Expanded] DOI Mutlu, M., Mutlu, P., YALÇIN-AZARKAN, S., Bayır, Ö., Saylam, G., Korkmaz, M.H. (2020) "Evaluation of methylation profiles of an epidermal growth factor receptor gene in a head and neck squamous cell carcinoma patient group", BALKAN JOURNAL OF MEDICAL GENETICS, 23 (2) pp. 65-72 [SCI Expanded] DOI
Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Gündüz, U. (2020) "Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery", ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 20 (10) pp. 1233-1240 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21709">
Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Gündüz, U. (2020) "Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery", ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 20 (10) pp. 1233-1240 [SCI Expanded] DOI Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Gündüz, U. (2020) "Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery", ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 20 (10) pp. 1233-1240 [SCI Expanded] DOI
YALÇIN-AZARKAN, S. (2020) "Molecular Docking, Drug Likeness, and ADMET Analyses of PassifloraCompounds as P-Glycoprotein (P-gp) Inhibitor for the Treatmentof Cancer", Current Pharmacology Reports, (0) " data-bs-content-id="YazarBilgi-21710">
YALÇIN-AZARKAN, S. (2020) "Molecular Docking, Drug Likeness, and ADMET Analyses of PassifloraCompounds as P-Glycoprotein (P-gp) Inhibitor for the Treatmentof Cancer", Current Pharmacology Reports, (0) YALÇIN-AZARKAN, S. (2020) "Molecular Docking, Drug Likeness, and ADMET Analyses of PassifloraCompounds as P-Glycoprotein (P-gp) Inhibitor for the Treatmentof Cancer", Current Pharmacology Reports, (0)
Köksal, R., YALÇIN-AZARKAN, S. (2020) "The Cytotoxic Effect of Annona muricata-Loaded PHB-CoatedMagnetic Nanoparticles on Cancer Cell Lines and Molecular DockingAnalyses", Current Pharmacology Reports, (0) " data-bs-content-id="YazarBilgi-21711">
Köksal, R., YALÇIN-AZARKAN, S. (2020) "The Cytotoxic Effect of Annona muricata-Loaded PHB-CoatedMagnetic Nanoparticles on Cancer Cell Lines and Molecular DockingAnalyses", Current Pharmacology Reports, (0) Köksal, R., YALÇIN-AZARKAN, S. (2020) "The Cytotoxic Effect of Annona muricata-Loaded PHB-CoatedMagnetic Nanoparticles on Cancer Cell Lines and Molecular DockingAnalyses", Current Pharmacology Reports, (0)
YALÇIN-AZARKAN, S., Mutlu, P., Ünsoy, G., Khodadust, R., Gündüz, U. (2020) "Doxorubicin-loaded magnetic nanoparticles downregulate expression of antiapoptoticgenes in resistant breast cancer cells", Journal ofMaterials NanoScience, (0) " data-bs-content-id="YazarBilgi-21712">
YALÇIN-AZARKAN, S., Mutlu, P., Ünsoy, G., Khodadust, R., Gündüz, U. (2020) "Doxorubicin-loaded magnetic nanoparticles downregulate expression of antiapoptoticgenes in resistant breast cancer cells", Journal ofMaterials NanoScience, (0) YALÇIN-AZARKAN, S., Mutlu, P., Ünsoy, G., Khodadust, R., Gündüz, U. (2020) "Doxorubicin-loaded magnetic nanoparticles downregulate expression of antiapoptoticgenes in resistant breast cancer cells", Journal ofMaterials NanoScience, (0)
KIRAY, E., Kariptaş, E., YALÇIN-AZARKAN, S. (2019) "Evaluation of Vaginal Lactobacilli with PotentialProbiotic Properties and Biotherapeutic Effectsisolated from Healthy Turkish Women", PSM Microbiology, (0) " data-bs-content-id="YazarBilgi-21713">
KIRAY, E., Kariptaş, E., YALÇIN-AZARKAN, S. (2019) "Evaluation of Vaginal Lactobacilli with PotentialProbiotic Properties and Biotherapeutic Effectsisolated from Healthy Turkish Women", PSM Microbiology, (0) KIRAY, E., Kariptaş, E., YALÇIN-AZARKAN, S. (2019) "Evaluation of Vaginal Lactobacilli with PotentialProbiotic Properties and Biotherapeutic Effectsisolated from Healthy Turkish Women", PSM Microbiology, (0)
YALÇIN-AZARKAN, S. (2019) "Dextran coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 24 (8) pp. 1032-1037 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21716">
YALÇIN-AZARKAN, S. (2019) "Dextran coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 24 (8) pp. 1032-1037 [SCI Expanded] DOI YALÇIN-AZARKAN, S. (2019) "Dextran coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 24 (8) pp. 1032-1037 [SCI Expanded] DOI
Keskin, T., YALÇIN-AZARKAN, S., Gündüz, U. (2018) "Folic acid functionalized PEG coated magnetic nanoparticles for targeting anti-cancer drug delivery: Preparation, characterization and cytotoxicity on Doxorubicin, Zoledronic acid and Paclitaxel resistant MCF-7 breast cancer cell lines", INORGANIC AND NANO-METAL CHEMISTRY, 48 (2) pp. 150-159 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21718">
Keskin, T., YALÇIN-AZARKAN, S., Gündüz, U. (2018) "Folic acid functionalized PEG coated magnetic nanoparticles for targeting anti-cancer drug delivery: Preparation, characterization and cytotoxicity on Doxorubicin, Zoledronic acid and Paclitaxel resistant MCF-7 breast cancer cell lines", INORGANIC AND NANO-METAL CHEMISTRY, 48 (2) pp. 150-159 [SCI Expanded] DOI Keskin, T., YALÇIN-AZARKAN, S., Gündüz, U. (2018) "Folic acid functionalized PEG coated magnetic nanoparticles for targeting anti-cancer drug delivery: Preparation, characterization and cytotoxicity on Doxorubicin, Zoledronic acid and Paclitaxel resistant MCF-7 breast cancer cell lines", INORGANIC AND NANO-METAL CHEMISTRY, 48 (2) pp. 150-159 [SCI Expanded] DOI
Mutlu, P., YALÇIN-AZARKAN, S., Pourianazar, N.T., Meral, Y., Gündüz, U. (2018) "Determınatıon Of The Relatıonshıp Between Doxorubıcın Resıstance And Wnt Sıgnalıng Pathway In Hela And K562 Cell Lınes", EXCLI JOURNAL, 17 (0) pp. 386-398 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21720">
Mutlu, P., YALÇIN-AZARKAN, S., Pourianazar, N.T., Meral, Y., Gündüz, U. (2018) "Determınatıon Of The Relatıonshıp Between Doxorubıcın Resıstance And Wnt Sıgnalıng Pathway In Hela And K562 Cell Lınes", EXCLI JOURNAL, 17 (0) pp. 386-398 [SCI Expanded] DOI Mutlu, P., YALÇIN-AZARKAN, S., Pourianazar, N.T., Meral, Y., Gündüz, U. (2018) "Determınatıon Of The Relatıonshıp Between Doxorubıcın Resıstance And Wnt Sıgnalıng Pathway In Hela And K562 Cell Lınes", EXCLI JOURNAL, 17 (0) pp. 386-398 [SCI Expanded] DOI
YALÇIN-AZARKAN, S., Öngürü, Ö. (2017) "BRAF mutation in colorectal carcinomas with signet ring cell component", CANCER BIOLOGY & MEDICINE, 14 (3) pp. 287-292 [SCI Expanded] DOI " data-bs-content-id="YazarBilgi-21721">
YALÇIN-AZARKAN, S., Öngürü, Ö. (2017) "BRAF mutation in colorectal carcinomas with signet ring cell component", CANCER BIOLOGY & MEDICINE, 14 (3) pp. 287-292 [SCI Expanded] DOI YALÇIN-AZARKAN, S., Öngürü, Ö. (2017) "BRAF mutation in colorectal carcinomas with signet ring cell component", CANCER BIOLOGY & MEDICINE, 14 (3) pp. 287-292 [SCI Expanded] DOI
YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance inBreast Cancer", Journal of Nanomedicine and nanotechnology, (0) " data-bs-content-id="YazarBilgi-21722">
YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance inBreast Cancer", Journal of Nanomedicine and nanotechnology, (0) YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance inBreast Cancer", Journal of Nanomedicine and nanotechnology, (0)
Öngürü, Ö., YALÇIN-AZARKAN, S., Rosemblit, C., Zhang, P., Kılıç, S., Gündüz, U. (2016) "APOBEC3B expression in drug resistant MCF 7 breast cancer cell lines", BIOMEDICINE & PHARMACOTHERAPY, 79 (0) pp. 87-92 [SCI Expanded] Link DOI " data-bs-content-id="YazarBilgi-21723">
Öngürü, Ö., YALÇIN-AZARKAN, S., Rosemblit, C., Zhang, P., Kılıç, S., Gündüz, U. (2016) "APOBEC3B expression in drug resistant MCF 7 breast cancer cell lines", BIOMEDICINE & PHARMACOTHERAPY, 79 (0) pp. 87-92 [SCI Expanded] Link DOI Öngürü, Ö., YALÇIN-AZARKAN, S., Rosemblit, C., Zhang, P., Kılıç, S., Gündüz, U. (2016) "APOBEC3B expression in drug resistant MCF 7 breast cancer cell lines", BIOMEDICINE & PHARMACOTHERAPY, 79 (0) pp. 87-92 [SCI Expanded] Link DOI
YALÇIN-AZARKAN, S., Özlüer, Ö., Gündüz, U. (2016) "Nanoparticle based drug delivery in cancer the role of cell membrane structures", THERAPEUTIC DELIVERY, 7 (11) pp. 773-781 [ESCI] DOI " data-bs-content-id="YazarBilgi-21724">
YALÇIN-AZARKAN, S., Özlüer, Ö., Gündüz, U. (2016) "Nanoparticle based drug delivery in cancer the role of cell membrane structures", THERAPEUTIC DELIVERY, 7 (11) pp. 773-781 [ESCI] DOI YALÇIN-AZARKAN, S., Özlüer, Ö., Gündüz, U. (2016) "Nanoparticle based drug delivery in cancer the role of cell membrane structures", THERAPEUTIC DELIVERY, 7 (11) pp. 773-781 [ESCI] DOI
Parisan, M., Ünsoy, G., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti cancer efficacy of the drug", EUROPEAN JOURNAL OF PHARMACOLOGY, 784 (0) pp. 121-128 [SCI Expanded] Link DOI " data-bs-content-id="YazarBilgi-21725">
Parisan, M., Ünsoy, G., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti cancer efficacy of the drug", EUROPEAN JOURNAL OF PHARMACOLOGY, 784 (0) pp. 121-128 [SCI Expanded] Link DOI Parisan, M., Ünsoy, G., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti cancer efficacy of the drug", EUROPEAN JOURNAL OF PHARMACOLOGY, 784 (0) pp. 121-128 [SCI Expanded] Link DOI
Erdem, M., YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Folic acid conjugated polyethylene glycol coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy Preparation characterization and cytotoxicity on HeLa cell line", Human & Experimental Toxicology, (0) [SCI Expanded] Link DOI " data-bs-content-id="YazarBilgi-21726">
Erdem, M., YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Folic acid conjugated polyethylene glycol coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy Preparation characterization and cytotoxicity on HeLa cell line", Human & Experimental Toxicology, (0) [SCI Expanded] Link DOI Erdem, M., YALÇIN-AZARKAN, S., Gündüz, U. (2016) "Folic acid conjugated polyethylene glycol coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy Preparation characterization and cytotoxicity on HeLa cell line", Human & Experimental Toxicology, (0) [SCI Expanded] Link DOI
Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, 515 (1) pp. 104-113 [SCI Expanded] Link DOI " data-bs-content-id="YazarBilgi-21727">
Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, 515 (1) pp. 104-113 [SCI Expanded] Link DOI Parsian, M., Mutlu, P., YALÇIN-AZARKAN, S., Tezcaner, A., Gündüz, U. (2016) "Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, 515 (1) pp. 104-113 [SCI Expanded] Link DOI
Pelin, M., Murad, M., YALÇIN-AZARKAN, S., Atılay, Y., Gozde, U., Güleser, S., İstemihan, A., Ufuk, G., Korkmaz, H. (2015) "Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population", EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 272 (12) pp. 3779-3784 [SCI Expanded] Link DOI " data-bs-content-id="YazarBilgi-21728">
Pelin, M., Murad, M., YALÇIN-AZARKAN, S., Atılay, Y., Gozde, U., Güleser, S., İstemihan, A., Ufuk, G., Korkmaz, H. (2015) "Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population", EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 272 (12) pp. 3779-3784 [SCI Expanded] Link DOI Pelin, M., Murad, M., YALÇIN-AZARKAN, S., Atılay, Y., Gozde, U., Güleser, S., İstemihan, A., Ufuk, G., Korkmaz, H. (2015) "Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population", EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 272 (12) pp. 3779-3784 [SCI Expanded] Link DOI
